Alternatives to Creative Biolabs

A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services.

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

RD-Biotech develops innovative solutions for drug discovery and development using advanced biotechnology.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

AI-guided drug discovery platform for tissue-targeted medicines.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

Develops novel therapeutic antibodies for oncology and autoimmune diseases.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

Biotechnology company specializing in antibody discovery and protein engineering for therapeutic applications.

Mabylon is a biotechnology company focused on developing innovative antibody-based therapies for infectious diseases and cancer.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered platform for understanding disease biology and accelerating drug discovery.

Combines human immune organoid biology with generative AI to reduce immunogenicity risk in antibody development.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.